Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
about
Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia.Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaDesign issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation.Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study.Molecular characterization of fungal populations on the tongue dorsum of institutionalized elderly adults.Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxPosaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Current role of echinocandins in the management of invasive aspergillosis.Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
P2860
Q34997741-9AA5D7F1-AF23-413F-95E8-2BB789641261Q36774247-865F41AC-E5A2-4F13-9F7D-AE0E7C1075E1Q37043539-F9DAA649-1777-411E-986B-633E26D3547FQ37473671-12093AB0-CF29-4E32-9A00-FA2E034B1B71Q37833638-F9714BC8-5701-4583-85B3-6AE2D5D2EA9BQ40153913-7D091564-C298-4D1A-A25F-761BF812C8F8Q40241173-A41A7D3A-3ED7-4448-B3A3-089C8C43A8DDQ40285259-B36A7AD0-B2F7-45FA-AB03-400BC1C84DD9Q40317253-003C077B-789F-466A-9992-456E73218994Q42874381-243FC449-CE16-4712-8119-86A9EAD31E17Q43600554-EC19540A-926C-4EFE-90F6-5AC5B799784DQ43986685-3AB39D62-9E79-4770-AE5C-8168D5A6664AQ50072321-D755B2F2-596C-4773-BB12-5509135DF249Q53217028-873F0AC2-203E-46E2-8F75-C434FBC6759DQ57208471-74F1AC47-B22D-4047-B85D-31B8DC99128A
P2860
Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Empirical antifungal therapy i ...... rrent fever of unknown origin.
@en
type
label
Empirical antifungal therapy i ...... rrent fever of unknown origin.
@en
prefLabel
Empirical antifungal therapy i ...... rrent fever of unknown origin.
@en
P2860
P1476
Empirical antifungal therapy i ...... rrent fever of unknown origin.
@en
P2093
Claudio Viscoli
Rodrigo Martino
P2860
P304
P356
10.1111/J.1365-2141.2005.05838.X
P407
P577
2006-01-01T00:00:00Z